Dr. Reddy's Laboratories Limited Cost of Revenue | RDY

Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.

What is included in the cost of revenue

Cost Category	Examples
Production Costs	Materials, wages of production staff, depreciation of equipment
Service and Support	Customer service, user support, technical assistance
Delivery and Logistics	Packaging, delivery of goods to customers
Hosting and Infrastructure	Servers, cloud platforms (especially for IT and SaaS companies)
Content and Licenses	License purchases, production royalties (e.g., in streaming services)

Importance of the Metric

Helps to understand how costly the revenue-generating process is.
A high cost of revenue may indicate:
Poor cost control
Low operational efficiency
A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.

Annual Cost of Revenue Dr. Reddy's Laboratories Limited

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
135 B	116 B	107 B	101 B	86.6 B	80.6 B	70.4 B	65.7 B	62.5 B	62.4 B	-	-	-	-	-

All numbers in INR currency

Indicator range from annual reports

Maximum	Minimum	Average
135 B	62.4 B	88.6 B

Quarterly Cost of Revenue Dr. Reddy's Laboratories Limited

2025-Q4	2025-Q1	2024-Q4	2024-Q1	2023-Q4	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	135 B	-	116 B	-	107 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in INR currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
135 B	107 B	119 B

Cost of Revenue of other stocks in the Biotechnology industry

Issuer	Cost of Revenue	Price	% 24h	Market Cap	Country
Ionis Pharmaceuticals IONS	15.9 M	$ 43.5	0.62 %	$ 6.96 B	USA
Agios Pharmaceuticals AGIO	6.34 M	$ 31.25	0.88 %	$ 1.81 B	USA
Kamada Ltd. KMDA	104 M	$ 8.0	1.34 %	$ 461 M	Israel
Ultragenyx Pharmaceutical RARE	1.15 M	$ 14.5	3.19 %	$ 1.43 B	USA
Viridian Therapeutics VRDN	2.55 M	$ 19.0	2.16 %	$ 1.93 B	USA
AbbVie ABBV	18.2 B	$ 265.76	1.12 %	$ 470 B	USA
Abeona Therapeutics ABEO	1.53 M	$ 5.11	1.59 %	$ 271 M	USA
ACADIA Pharmaceuticals ACAD	89 M	$ 20.11	0.8 %	$ 3.39 B	USA
Aclaris Therapeutics ACRS	2.09 M	$ 4.27	0.79 %	$ 523 M	USA
ADC Therapeutics SA ADCT	5.8 M	$ 1.23	8.85 %	$ 156 M	Schweiz
ADMA Biologics ADMA	217 M	$ 10.11	4.01 %	$ 2.41 B	USA
Adaptive Biotechnologies Corporation ADPT	71.4 M	$ 29.84	5.26 %	$ 4.53 B	USA
Agenus AGEN	1.02 M	$ 8.73	4.43 %	$ 260 M	USA
AIM ImmunoTech AIM	1.25 M	$ 0.19	5.56 %	$ 308 K	USA
Akebia Therapeutics AKBA	39.5 M	$ 0.91	5.26 %	$ 234 M	USA
Alector ALEC	51.8 M	$ 1.99	9.94 %	$ 205 M	USA
Alkermes plc ALKS	196 M	$ 42.76	2.42 %	$ 7.04 B	Irlanda
Alnylam Pharmaceuticals ALNY	677 M	$ 219.89	0.08 %	$ 28.8 B	USA
Amgen AMGN	12 B	$ 402.98	0.08 %	$ 217 B	USA
Amphastar Pharmaceuticals AMPH	364 M	$ 25.37	0.39 %	$ 1.19 B	USA
Amarin Corporation plc AMRN	96 M	$ 12.09	0.31 %	$ 5.02 B	Irlanda
Amneal Pharmaceuticals AMRX	1.91 B	$ 20.35	0.25 %	$ 6.38 B	USA
Anika Therapeutics ANIK	49 M	$ 19.73	3.3 %	$ 283 M	USA
ANI Pharmaceuticals ANIP	341 M	$ 72.58	0.55 %	$ 1.46 B	USA